🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Item Information and Pricing

Inside these communities, messages display dark colored parcels with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to potentially significant medical dangers”.